Aplastic Anemia and Agranulocytosis in Patients Using Methazolamide for Glaucoma

Theodore P. Werblin, Irvin P. Pollack, Robert A. Liss

Research output: Contribution to journalArticlepeer-review

Abstract

Carbonic anhydrase inhibitors used in the treatment of glaucoma, seizure disorders, and hypertension are rarely associated with blood dyscrasias. Several case reports of aplastic anemia with use of acetazolamide, and two cases with use of methazolamide, have appeared in the literature. This article describes two cases of aplastic anemia, at least one of which was almost certainly induced by the use of methazolamide, and one case of agranulocytosis related to the use of methazolamide. (JAMA 241:2817-2818, 1979).

Original languageEnglish (US)
Pages (from-to)2817-2818
Number of pages2
JournalJAMA: The Journal of the American Medical Association
Volume241
Issue number26
DOIs
StatePublished - Jun 29 1979

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Aplastic Anemia and Agranulocytosis in Patients Using Methazolamide for Glaucoma'. Together they form a unique fingerprint.

Cite this